EBV and MS: Major cause, minor contribution or red-herring?

Area of Science:

• Neuroimmunology
• Virology
• Chronic Neurological Diseases

Background:

• Multiple Sclerosis (MS) is a chronic neurological disease with known genetic and environmental risk factors.
• Epstein-Barr Virus (EBV) is strongly associated with MS, but evidence remains conflicting.
• Key evidence includes high EBV seroprevalence in MS patients and altered immune responses to EBV.

Purpose of the Study:

• To review and evaluate current theories on Epstein-Barr Virus (EBV) involvement in Multiple Sclerosis (MS) pathogenesis.
• To analyze conflicting evidence regarding EBV's role in MS.
• To explore proposed mechanisms of EBV-induced MS.

Main Methods:

• Literature review of studies investigating the association between Epstein-Barr Virus (EBV) and Multiple Sclerosis (MS).
• Analysis of evidence supporting and refuting EBV's direct or indirect role in MS.
• Evaluation of proposed pathogenetic mechanisms, including molecular mimicry and bystander damage.

Main Results:

• Nearly all MS patients exhibit past EBV infection, with associations to infectious mononucleosis and higher antibody titers.
• Conflicting data exists regarding EBV presence in cerebrospinal fluid (CSF) and T-cell responses in MS patients.
• Hypotheses include molecular mimicry, mistaken self, bystander damage, and EBV-infected autoreactive B cells.

Conclusions:

• The precise role of Epstein-Barr Virus (EBV) in Multiple Sclerosis (MS) pathogenesis requires further investigation.
• Conflicting evidence necessitates a critical evaluation of proposed mechanisms.
• Alternative hypotheses, including a general failure of viral clearance, warrant consideration in MS etiology.